Conclusion Fosfomycin may be a choice to treat clinical infect with multiresistant Escherichia coli.
结论磷霉素可以成为治疗临床多重耐药大肠杆菌感染的一种选择。
Objective To evaluate the drug sensitive effect of fosfomycin on clinical multiresistant Escherichia coli in vitro.
目的评价磷霉素对多重耐药大肠埃希菌的体外药敏效应。
CONCLUSIONS: Multiresistant phenotypes of MRSA were different, and also antimicrobial resistance of MRSA and MSSA was some differences between Beijing and Hubei regions.
结论：北京和湖北地区MRSA表型多重耐药谱存在差别，MRSA和MSSA对抗生素耐药性也有不同。
CONCLUSIONS: Multiresistant phenotypes of MRSA were different, and also antimicrobial resistance of MRSA and MSSA was some differences between Beijing and Hubei regions.
结论：北京和湖北地区MRSA表型多重耐药谱存在差别，MRSA和MSSA对抗生素耐药性也有不同。
应用推荐